Amazon Q4 Preview: Asymmetric Downside If AWS Prints Below $34.9B In Revenue
seekingalpha.com
Want to monitor TRVI?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor TRVITrevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF).